Navigation

Product search

Language

Share

Cardiovascular and Cerebrovascular Diseases Diagnostic Assay Kits Company

Home / Product / Cardiovascular and Cerebrovascular Diseases
Product Category:
Cardiovascular and Cerebrovascular Diseases
Product:

Cardiovascular and Cerebrovascular Diseases Diagnostic Test Kits Manufacturers

Zhejiang Kangte Biotechnology Co., Ltd is outstanding China Cardiovascular and Cerebrovascular Diseases Diagnostic Test Kits Manufacturers and Cardiovascular and Cerebrovascular Diseases Diagnostic Test Kits company. We OEM/ODM Clinical Reagent Test kit For Cardiovascular and Cerebrovascular Diseases. The company has obtained a number of invention patents and utility model patents and has passed ISO9001, ISO14001, ISO13485, and other system certifications. The company currently has more than 100 registered products, covering biochemical, immunological, and other fields, and many of the products have reached the leading domestic level in technology.

About Kangte

Zhejiang Kangte Biotechnology Co., Ltd

Zhejiang Kangte Biotechnology Co., Ltd. was established in 2001 and is located in Zhejiang Xinchang Provincial High-tech Industrial Park. It is a national high-tech enterprise integrating R&D, production and sales of in vitro diagnostic reagents. Relying on the pioneering team spirit and scientific management, the company has repeatedly won the national advanced production unit in the in vitro diagnostic industry. 

The company has GMP standard workshops, clean workshops, R&D laboratories, equipped with high-precision testing equipment and fully automatic production equipment. In order to enhance the company's overall R&D strength, it has established a good "production-study-research" cooperative relationship with many colleges and universities. The company has obtained a number of invention patents and utility model patents and has passed ISO9001, ISO14001, ISO13485, and other system certifications. The company currently has more than 100 registered products, covering biochemical, immunological, and other fields, and many of the products have reached the leading domestic level in technology. 

The company adheres to the concept of "integrity, professionalism, efficiency and innovation" to serve customers, and constantly introduces products with higher technological content to provide customers. The company will, as always, position itself in "service technology, professionalism and efficiency, and achieve customers", and work hard to jointly shape the IVD industry and continuously improve the level of human health.

 

  • 0+

    Registered products

  • 0+

    Cooperative Hospital

  • 0+

    Researchers

  • 0+

    Certificates

  • 0years+

    Working experience

News

INDUSTRY KNOWLEDGE EXTENSION
How specific are the assay kits in distinguishing between different cardiovascular and cerebrovascular conditions?
The specificity of Cardiovascular And Cerebrovascular Diseases Diagnostic Assay Kits in distinguishing between different cardiovascular and cerebrovascular conditions can vary based on the design, targets, and technology employed in the assays.
Biomarker Selection:
The choice of biomarkers targeted by the assay kits is critical. Some diseases may share common biomarkers, and the ability to differentiate between them relies on selecting highly specific indicators for each condition.
Panel Design:
Multi-marker panels can enhance specificity by considering a combination of biomarkers associated with different diseases. This approach allows for a more comprehensive assessment and reduces the likelihood of misdiagnosis.
Cross-Reactivity Testing:
Rigorous testing is essential to identify and minimize cross-reactivity with substances or conditions unrelated to the targeted diseases. This ensures that the assay specifically detects the intended biomarkers without interference.
Clinical Validation:
Extensive clinical validation studies involving diverse patient populations with various cardiovascular and cerebrovascular conditions are crucial. These studies assess the assay's performance in real-world scenarios, evaluating its ability to differentiate between different diseases.
Diagnostic Algorithm:
Some Cardiovascular And Cerebrovascular Diseases Diagnostic Assay Kits may use sophisticated algorithms to analyze multiple biomarkers and generate a diagnostic output. The specificity of these algorithms depends on their complexity and the quality of the data used for development.
What is the range of conditions that the diagnostic assay kits can detect within the cardiovascular and cerebrovascular spectrum？
Diagnostic assay kits for Cardiovascular And Cerebrovascular Diseases Diagnostic Assay Kits are designed to detect specific markers or analytes associated with various diseases or conditions within this spectrum. The range of conditions that these kits can detect depends on the markers included in the assay and the intended purpose of the kit. 
Cardiac Markers:
Myocardial Infarction (Heart Attack): Kits may detect cardiac troponins (troponin I, troponin T) and creatine kinase-MB (CK-MB), which are released into the bloodstream when there is damage to the heart muscle.Other Heart Conditions: Brain natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are markers associated with heart failure.
Lipid Profile:
Hyperlipidemia: Kits measuring total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides can assess lipid profiles linked to cardiovascular risk.
Coagulation and Hemostasis:
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): D-dimer is a marker often used to aid in the diagnosis of these conditions.
Anticoagulation Monitoring: Kits may be used to monitor levels of anticoagulant medications like warfarin.
Inflammatory Markers:
Atherosclerosis and Inflammatory Conditions: High-sensitivity C-reactive protein (hs-CRP) is an inflammatory marker associated with cardiovascular risk.
Hypertension:
Blood Pressure Monitoring: Although not typically part of a diagnostic assay kit, blood pressure measurements are crucial for assessing hypertension, a significant cardiovascular risk factor.
Stroke and Cerebrovascular Events:
Ischemic Stroke: Kits may include markers like brain natriuretic peptide (BNP) or D-dimer to aid in the diagnosis of ischemic stroke.
Hemorrhagic Stroke: Hemoglobin or hematocrit levels may be measured to assess bleeding in the brain.